A detailed history of Chartwell Investment Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 247,844 shares of MRK stock, worth $24.3 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
247,844
Previous 263,035 5.78%
Holding current value
$24.3 Million
Previous $32.6 Million 13.57%
% of portfolio
0.97%
Previous 1.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$111.15 - $128.97 $1.69 Million - $1.96 Million
-15,191 Reduced 5.78%
247,844 $28.1 Million
Q2 2024

Aug 08, 2024

BUY
$123.8 - $132.96 $634,722 - $681,685
5,127 Added 1.99%
263,035 $32.6 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $2.76 Million - $3.22 Million
-24,389 Reduced 8.64%
257,908 $34 Million
Q4 2023

Feb 15, 2024

BUY
$100.18 - $109.02 $838,005 - $911,952
8,365 Added 3.05%
282,297 $30.8 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $909,769 - $1.01 Million
8,837 Added 3.33%
273,932 $28.2 Million
Q2 2023

Jul 25, 2023

BUY
$108.61 - $118.38 $494,501 - $538,984
4,553 Added 1.75%
265,095 $30.6 Million
Q1 2023

Apr 14, 2023

SELL
$102.94 - $114.86 $1.13 Million - $1.26 Million
-10,996 Reduced 4.05%
260,542 $27.7 Million
Q4 2022

Feb 15, 2023

BUY
$87.44 - $112.11 $4.44 Million - $5.69 Million
50,781 Added 23.0%
271,538 $30.1 Million
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $1.59 Million - $1.79 Million
18,851 Added 9.34%
220,757 $19 Million
Q2 2022

Aug 01, 2022

SELL
$83.49 - $94.64 $2.44 Million - $2.77 Million
-29,235 Reduced 12.65%
201,906 $18.4 Million
Q1 2022

Apr 26, 2022

SELL
$73.51 - $82.4 $1.3 Million - $1.46 Million
-17,750 Reduced 7.13%
231,141 $19 Million
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $746,218 - $934,734
10,324 Added 4.33%
248,891 $19.1 Million
Q3 2021

Nov 16, 2021

BUY
$71.68 - $78.83 $1.52 Million - $1.67 Million
21,232 Added 9.77%
238,567 $17.9 Million
Q2 2021

Jul 19, 2021

SELL
$70.31 - $77.77 $8.51 Million - $9.42 Million
-121,097 Reduced 35.78%
217,335 $16.9 Million
Q1 2021

May 03, 2021

BUY
$68.86 - $81.11 $526,228 - $619,842
7,642 Added 2.31%
338,432 $26.1 Million
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $2.24 Million - $2.48 Million
-31,189 Reduced 8.62%
330,790 $27.1 Million
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $374,242 - $424,206
-5,114 Reduced 1.39%
361,979 $30 Million
Q2 2020

Jul 29, 2020

BUY
$70.42 - $80.13 $621,033 - $706,666
8,819 Added 2.46%
367,093 $28.4 Million
Q1 2020

Apr 30, 2020

BUY
$63.36 - $87.82 $1.81 Million - $2.51 Million
28,586 Added 8.67%
358,274 $27.6 Million
Q4 2019

Jan 29, 2020

SELL
$77.58 - $87.54 $115,826 - $130,697
-1,493 Reduced 0.45%
329,688 $30 Million
Q3 2019

Oct 29, 2019

SELL
$76.08 - $82.93 $1.99 Million - $2.16 Million
-26,093 Reduced 7.3%
331,181 $27.9 Million
Q2 2019

Aug 19, 2019

BUY
$69.84 - $81.59 $1.26 Million - $1.48 Million
18,083 Added 5.33%
357,274 $30 Million
Q1 2019

Apr 11, 2019

BUY
$69.58 - $79.36 $554,413 - $632,340
7,968 Added 2.41%
339,191 $28.2 Million
Q4 2018

Feb 01, 2019

SELL
$65.24 - $75.71 $1.17 Million - $1.36 Million
-17,985 Reduced 5.15%
331,223 $25.3 Million
Q3 2018

Nov 08, 2018

BUY
$57.69 - $67.84 $1.75 Million - $2.06 Million
30,414 Added 9.54%
349,208 $24.8 Million
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $2.48 Million - $2.92 Million
48,829 Added 18.09%
318,794 $19.4 Million
Q1 2018

May 08, 2018

SELL
$50.96 - $59.23 $314,678 - $365,745
-6,175 Reduced 2.24%
269,965 $15.2 Million
Q1 2018

May 08, 2018

BUY
$50.96 - $59.23 $314,678 - $365,745
6,175 Added 2.29%
276,140 $15 Million
Q4 2017

Feb 08, 2018

SELL
$51.62 - $61.64 $1.45 Million - $1.73 Million
-28,120 Reduced 9.43%
269,965 $15.2 Million
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $17.5 Million - $18.8 Million
298,085
298,085 $19.1 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.